Summary Thirty-one cervical biopsies of invasive carcinoma have been studied by immunohistochemical means using the monoclonal antibody Ki67 to determine tumour cell proliferation rates. A wide range (10-50%) in the extent of Ki67 staining (expressed as the percentage of labelled tumour cells) was observed indicating considerable variation on tumour growth rates. There was no significant relationship between the percentage of positive cells and conventional histological parameters such as cell type or tumour differentiation. Immunostaining with monoclonal antibody Ki67 therefore provides a new approach to the assessment of cervical tumour biopsies which will require long term clinical follow-up to establish its prognostic significance.
Carcinoma of the cervix is currently the subject of considerable attention since it is hoped that extensive screening programmes coupled with effective early treatment will prevent later invasive disease. Nevertheless the prevalence of invasive cervical cancer remains high and there is evidence that its incidence is rising, particularly amongst younger sexually active women (MacGregor, 1982) .
The clinical behaviour of invasive carcinoma of the cervix is not uniform but covers a wide spectrum from cases that are relatively indolent to those having a rapidly progressive course (Richart & Barton, 1969 (Ng & Atkin, 1973; van Nagell et al., 1977; Bobrow et al., 1986) and opponents (Crissman et al., 1985; Goellner, 1976; Wells et al., 1986; Fray et al., 1984) .
Measurement of the tumour growth fraction in cervical carcinoma appears to offer a potentially valuable approach to this problem but has not been widely introduced due to the time consuming and technically difficult nature of methods involving the incorporation of DNA precursors tritiated thymidine or bromodeoxyuridine into tumour cells. Recently a monoclonal antibody Ki67 has been developed which identifies a nuclear antigen in human cells at all stages of the cell cycle except Go (Gerdes et al., 1984a) . The chemical nature of the antigen recognized by Ki67 has not yet been determined and its functional role is unclear. However a good correlation has been shown between the immunocytochemical labelling of cell nuclei with Ki67 and other methods of assessing cell proliferation, e.g. flow cytometry and autoradiography (Gerdes et al., 1984a) .
Preliminary studies of lymphoma (Gerdes et al., 1984b; Hall et al., 1987) , breast cancer Barnard et al., 1987) and carcinoma of the lung (Gatter et al., 1986) 
Immunocytochemistry
Cryostat sections were stained with the monoclonal antibody Ki67 (DAKO-PC) using the APAAP immunoalkaline phosphatase technique (Cordell et al., 1984) . Routinely processed material (formalin fixed, paraffin-embedded) is unsuitable for staining with Ki67 since the antigen recognised by this antibody is destroyed by conventional fixation.
Proliferation assessment
The total number of cells and the number of positively labelled cells in a given area (2 mm2) were counted using a graticule. Five different randomly selected areas of the cryostat section were assessed and the number of positive cells expressed as a percentage of the total number of cells (>500) (Goellner, 1976) . The grade was increased as the degree of disorderliness and pleomorphism, lack of keratinization, and number of mitoses increased. Classification by cell type was performed according to the criteria used by Reagan et al. (1957) . They separated cervical squamous cell carcinomas into three groups; large cell nonkeratinizing, large cell keratinizing, and small cell carcinomas. In addition, in this study, adenocarcinomas were included as a separate group.
Results
The histogram in Figure plots the number of cases against the percentage of cells (which divided conveniently into 4 groups) labelled with the monoclonal antibody Ki67 for 21 squamous cell carcinomas and 6 adenocarcinomas of the cervix uteri. The 4 remaining cases of squamous cell carcinoma were eliminated from this study due to cytoplasmic labelling which made accurate estimation of nuclear staining impossible. Between individual cases the percentage of labelled nuclei showed wide variation over a range of 10-50% (Figure 1 ). There was also a smaller variation (± 10%) amongst different areas within an individual biopsy. The counting and averaging of results from 5 randomly chosen fields gave consistently reproducible results thus overcoming the problem of intra-biopsy variation in Ki67 staining. Examples of the immunohistological staining patterns using Ki67 are illustrated in Figure 2 . It was noticeable that the number of labelled nuclei was highest around the periphery of tumour islands particularly when the central area showed evidence of differentiation (Figure 2c ). There was no signifi- 
Discussion
There have been many attempts to use histological criteria to predict the clinical behaviour of carcinoma of the cervix, mostly with little or no success. Goellner (1976) Immunohistochemistry has as yet been of limited value as a tool for predicting behaviour of cervical dysplasia and neoplasia. Bobrow et al. (1986) have suggested that a change in cytokeratin expression by neoplastic cervical epithelium (CIN) as reflected by different degrees of staining with the anti-cytokeratin antibody CAM 5.2, may be a marker of invasive potential. This conclusion has not however been confirmed by a similar study conducted by Wells et al. (1986 ). Fray et al. (1984 studied tumour associated antigens detected by four different monoclonal antibodies (HMFG-1 and 2, Cal and anti-CEA) but found their prognostic significance to be limited.
There is evidence to suggest that tumour proliferation rates are related to clinical behaviour (Straus et al., 1983) .
As early as 1966 Breur showed that with increasing tumour doubling time the length of survival from presentation to death progressively increased. More recent studies using tritiated thymidine labelling index as a kinetic parameter in patients with breast carcinoma support these findings by showing that a low labelling index is associated with a better prognosis (Meyer et al., 1978; Straus & Moran, 1980 (Gerdes and Stein, personal communication) . Recently a technique for staining nucleolar organizer regions in tissue sections has been described as a possible method for assessing prognosis in tumours such as lymphoma (Crocker & Nar, 1987) and melanocytic lesions (Crocker & Skilbeck, 1987 (Prioleau et al., 1980) .
The most important question raised by this study, as in the case of other tumour types, e.g. lung (Gatter et al., 1986) and breast 
